Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autonomic Determinants of Postural Tachycardia Syndrome
NCT04050410Phase 1Active, not recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postural orthostatic tachycardia syndrome (POTS) comparing Moxonidine with Placebo (2 arms). Primary endpoint: Change in Orthostatic Symptom Burden. Started Aug 2019; status: active, not recruiting.
02
Drugs
moxonidine
03
Conditions
postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on NCT04050410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050410.